Meiji Yasuda Asset Management CO Ltd. Amgen Inc Transaction History

Meiji Yasuda Asset Management CO Ltd.

  • $2.57 Billion
  • Q3 2024

A detailed history of Meiji Yasuda Asset Management CO Ltd. transactions in Amgen Inc stock. As of the latest transaction made, Meiji Yasuda Asset Management CO Ltd. holds 20,520 shares of AMGN stock, worth $6.04 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares
20,520
Previous 20,545 0.12%
Holding current value
$6.04 Million
Previous $6.42 Million 2.99%
% of portfolio
0.26%
Previous 0.26%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024
SELL
$309.38 - $337.38 $7,734 - $8,434
-25 Reduced 0.12%
20,520 $6.61 Million
Q2 2024

Aug 12, 2024
BUY
$262.75 - $319.31 $146,089 - $177,536
556 Added 2.78%
20,545 $6.42 Million
Q1 2024

May 15, 2024
SELL
$268.87 - $324.56 $3.31 Million - $4 Million
-12,320 Reduced 38.13%
19,989 $5.68 Million
Q4 2023

Feb 14, 2024
BUY
$255.7 - $288.46 $2.34 Million - $2.63 Million
9,132 Added 39.4%
32,309 $9.31 Million
Q3 2023

Nov 13, 2023
BUY
$218.65 - $271.46 $1.11 Million - $1.38 Million
5,067 Added 27.98%
23,177 $6.23 Million
Q2 2023

Aug 14, 2023
SELL
$214.27 - $253.37 $244,053 - $288,588
-1,139 Reduced 5.92%
18,110 $4.02 Million
Q1 2023

May 09, 2023
SELL
$225.79 - $275.2 $1.15 Million - $1.4 Million
-5,091 Reduced 20.92%
19,249 $4.65 Million
Q4 2022

Feb 14, 2023
BUY
$229.03 - $291.01 $317,206 - $403,048
1,385 Added 6.03%
24,340 $6.39 Million
Q3 2022

Nov 14, 2022
SELL
$224.46 - $253.15 $250,272 - $282,262
-1,115 Reduced 4.63%
22,955 $5.17 Million
Q2 2022

Aug 16, 2022
BUY
$230.71 - $256.74 $521,635 - $580,489
2,261 Added 10.37%
24,070 $5.86 Million
Q1 2022

May 17, 2022
SELL
$219.27 - $242.57 $310,924 - $343,964
-1,418 Reduced 6.1%
21,809 $5.27 Million
Q4 2021

Feb 14, 2022
BUY
$198.88 - $227.6 $306,076 - $350,276
1,539 Added 7.1%
23,227 $5.23 Million
Q3 2021

Nov 12, 2021
SELL
$212.27 - $248.7 $204,628 - $239,746
-964 Reduced 4.26%
21,688 $4.61 Million
Q2 2021

Aug 13, 2021
SELL
$233.58 - $259.14 $161,870 - $179,584
-693 Reduced 2.97%
22,652 $5.52 Million
Q1 2021

May 14, 2021
BUY
$221.91 - $258.6 $2.38 Million - $2.77 Million
10,712 Added 84.79%
23,345 $5.81 Million
Q4 2020

Feb 12, 2021
BUY
$216.38 - $257.67 $461,754 - $549,867
2,134 Added 20.33%
12,633 $2.91 Million
Q3 2020

Nov 12, 2020
SELL
$234.65 - $260.95 $1.11 Million - $1.23 Million
-4,720 Reduced 31.01%
10,499 $2.67 Million
Q2 2020

Aug 13, 2020
BUY
$197.81 - $242.74 $1.28 Million - $1.57 Million
6,453 Added 73.61%
15,219 $3.59 Million
Q1 2020

May 14, 2020
SELL
$182.24 - $241.7 $1.44 Million - $1.91 Million
-7,915 Reduced 47.45%
8,766 $1.78 Million
Q4 2019

Feb 13, 2020
SELL
$189.21 - $243.2 $319,764 - $411,008
-1,690 Reduced 9.2%
16,681 $4.02 Million
Q3 2019

Nov 13, 2019
BUY
$174.11 - $208.62 $413,511 - $495,472
2,375 Added 14.85%
18,371 $3.56 Million
Q2 2019

Aug 13, 2019
SELL
$166.7 - $195.41 $147,029 - $172,351
-882 Reduced 5.23%
15,996 $2.95 Million
Q1 2019

May 14, 2019
SELL
$180.87 - $203.88 $150,122 - $169,220
-830 Reduced 4.69%
16,878 $3.21 Million
Q4 2018

Feb 12, 2019
SELL
$178.4 - $208.25 $137,546 - $160,560
-771 Reduced 4.17%
17,708 $3.45 Million
Q3 2018

Nov 13, 2018
BUY
$185.29 - $208.89 $188,995 - $213,067
1,020 Added 5.84%
18,479 $3.83 Million
Q2 2018

Aug 13, 2018
SELL
$166.05 - $186.51 $26,568 - $29,841
-160 Reduced 0.91%
17,459 $3.22 Million
Q1 2018

May 14, 2018
SELL
$169.43 - $198.0 $101,658 - $118,800
-600 Reduced 3.29%
17,619 $3 Million
Q4 2017

Feb 13, 2018
SELL
$168.79 - $188.59 $20,254 - $22,630
-120 Reduced 0.65%
18,219 $3.17 Million
Q3 2017

Nov 08, 2017
BUY
$167.29 - $191.0 $3.07 Million - $3.5 Million
18,339
18,339 $3.42 Million

Others Institutions Holding AMGN

# of Institutions
3,122
Shares Held
410M
Call Options Held
7.56M
Put Options Held
7.2M
View Full List

About AMGEN INC

AMGN Quotes by TradingView
  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $158B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Meiji Yasuda Asset Management CO Ltd. Portfolio

Follow Meiji Yasuda Asset Management CO Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Meiji Yasuda Asset Management CO Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Meiji Yasuda Asset Management CO Ltd. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email